Latest Technology News

Vitasora Health has completed the first tranche of its $11 million capital raise, positioning the company to fund growth initiatives and reach cash flow breakeven in the second half of fiscal 2026.

Viridis Mining and Minerals is set to reveal key findings from its Pre-Feasibility Study on the Colossus Rare Earth Element Project, highlighting its global significance and strong economic potential.

Betashares Capital Ltd has released the estimated annual distribution components for its S&P/ASX Australian Technology ETF (ATEC) for the 2024-25 financial year, highlighting a nuanced mix of income types and tax adjustments under the AMIT regime.

DroneShield Limited has landed a significant $11.7 million follow-on research contract from a Five Eyes Department of Defence customer, marking its fourth award from this strategic alliance.

Resonance Health is expanding its clinical trial operations with a third TrialsWest site in Mandurah, WA, set to open in August 2025, enhancing participant recruitment and supporting ongoing pharmaceutical trials.

BetMakers Technology Group has successfully closed an oversubscribed Share Purchase Plan, boosting its total capital raise to $13.7 million alongside a recent placement. The funds will support debt repayment, strategic acquisitions, and operational growth.

Nova Eye Medical has reported a record A$28.8 million in revenues for FY25, driven by strong US sales and sustained growth of its flagship iTrack™ Advance device.

TMK Energy has secured a drilling contract for its LF-07 production well, marking a key milestone in its Lucky Fox Pilot Well Project in Mongolia. The company also outlines an ambitious 2025 exploration program aimed at expanding its coal seam gas resources.

ClearVue Technologies announces key leadership changes with COO Douglas Hunt stepping in as interim CEO, alongside two new board appointments, signaling a strategic push to accelerate growth and innovation.

Amaero has successfully qualified its C103 and Ti64 metal powders through a collaboration with Auburn University’s NCAME, meeting Velo3D’s standards and paving the way for initial commercial shipments in FY2026.

BlinkLab has expanded its pivotal FDA autism diagnostic trial by adding the University of Nebraska Medical Center as a second U.S. clinical site, advancing toward broader validation and regulatory clearance.

Ryder Capital Limited has reported an impressive 27.5% pre-tax net tangible asset return for FY25, significantly outperforming key benchmarks and raising its fully franked final dividend to 5.5 cents per share.